BLB&G Partner Li Yu Speaks at Anti-Fraud Coalition 25th Annual Conference

November 5, 2025

BLB&G Partner Li Yu will contribute to a panel titled “Successfully Litigating Motions to Dismiss and Summary Judgment Motions in FCA Cases” at The Anti-Fraud Coalition’s 25th Annual Conference in Washington, D.C. on November 6. Li will join distinguished professionals to discuss strategies for opposing motions to dismiss under Rules 12(b)(6) and 9(b) and litigating motions for summary judgment under Rule 56 in FCA cases. The session will provide practical applications of foundational FCA legal principles, using recent decisions and sample briefings from multiple circuits to highlight key points.

Li serves as a lead partner of the firm’s Whistleblower Practice. A seasoned trial and appellate lawyer, Li is a recognized expert in qui tam cases and has led groundbreaking False Claims Act litigation against Medicare Advantage organizations, drug manufacturers, pharmacy chains, medical device suppliers, and mortgage lenders. He has secured over $800 million in settlements for kickback schemes, risk adjustment fraud, drug marketing fraud, and pharmacy billing fraud.

Previously, Li spoke on a titled “Working with Cooperators and Whistleblowers Across Cultures and Systems” at the Asian American Bar Association of New York 2025 Fall Conference.